Constitutional chromosomal aberration, t(4;12) (q23;p11), in a patient with Ph1 positive chronic myelocytic leukemia

A Randomized Comparison of Doxorubicin and Doxorubicin-DNA in the Treatment of Acute NonLymphoblastic Leukemia.

Leukemia & lymphoma·2016

Cytogenetic Findings and Survival in B-cell Chronic Lymphocytic Leukemia. Second IWCCLL Compilation of Data on 662 Patients.

Leukemia & lymphoma·2016

Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working Party.

Leukemia·2016

Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group.

Leukemia·2015

Autologous stem cell transplantation versus novel drugs or conventional chemotherapy for patients with relapsed multiple myeloma after previous ASCT.

Bone marrow transplantation·2015

Comparison of upfront tandem autologous-allogeneic transplantation versus reduced intensity allogeneic transplantation for multiple myeloma.

Bone marrow transplantation·2015

LncRNA FBXL19-AS1 regulates the miR-650/ITGB3 axis to drive pathological progression in Alzheimer's Disease.

Hereditas·2026

Esketamine induces ferroptosis and suppresses immune evasion in lung adenocarcinoma cells via the hsa_circ_0022392/miR-548b-3p/MAP7 axis.

Hereditas·2026

Preliminary functional characterization of the LMNA c.929 A > G (p.Gln310Arg) variant identified in a patient with dilated cardiomyopathy.

Hereditas·2026

LncRNA RASAL2-AS1 serves as a potential biomarker for prognosis and regulates cellular processes via the miR-590-5p/PDCD5 axis and Wnt/β-catenin pathway in cervical cancer.

Hereditas·2026

Hypoxia-activated DLL4/NOTCH-EDN1 signaling maintains fibroblast activation and endothelial crosstalk in a human dermal fibroblast model of keloid-like remodeling.

Hereditas·2026

The diagnostic value of miR-4281 for knee osteoarthritis and its mechanism of action on the extracellular matrix of chondrocytes and apoptosis.

Hereditas·2026

Leveraging non-concurrent controls for time-to-event endpoints in platform trials for infectious diseases.

Journal of biopharmaceutical statistics·2026

C5aR1 and C5aR2 deficiency confer different degrees of protection against imiquimod-induced psoriasiform dermatitis.

Clinical and experimental immunology·2026

Association of VISTA and BTLA polymorphisms with the risk of non-HBV and non-HCV related hepatocellular carcinoma in Western Guangxi, China: a pilot case-control study.

Personalized medicine·2026

An Observational Study of Programmed Cell Death In Hypertrophic Scars and Keloids Based on Bibliometric Analysis.

The Journal of craniofacial surgery·2026

Chronic Myeloid Leukemia Progressing to Early T-Cell Precursor Lymphoblastic Blast Phase Following Treatment Default: An Integrated Morphologic, Immunophenotypic, Cytogenetic, and Molecular Case Report.

Cureus·2026

Refining risk in historically high-risk pediatric B-cell acute lymphoblastic leukemia: response kinetics and outcomes.

Blood neoplasia·2026

Constitutional chromosomal aberration, t(4;12) (q23;p11), in a patient with Ph1 positive chronic myelocytic leukemia

Related Experiment Videos

Related Concept Videos

A Randomized Comparison of Doxorubicin and Doxorubicin-DNA in the Treatment of Acute NonLymphoblastic Leukemia.

Cytogenetic Findings and Survival in B-cell Chronic Lymphocytic Leukemia. Second IWCCLL Compilation of Data on 662 Patients.

Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working Party.

Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group.

Autologous stem cell transplantation versus novel drugs or conventional chemotherapy for patients with relapsed multiple myeloma after previous ASCT.

Comparison of upfront tandem autologous-allogeneic transplantation versus reduced intensity allogeneic transplantation for multiple myeloma.

LncRNA FBXL19-AS1 regulates the miR-650/ITGB3 axis to drive pathological progression in Alzheimer's Disease.

Esketamine induces ferroptosis and suppresses immune evasion in lung adenocarcinoma cells via the hsa_circ_0022392/miR-548b-3p/MAP7 axis.

Preliminary functional characterization of the LMNA c.929 A > G (p.Gln310Arg) variant identified in a patient with dilated cardiomyopathy.

LncRNA RASAL2-AS1 serves as a potential biomarker for prognosis and regulates cellular processes via the miR-590-5p/PDCD5 axis and Wnt/β-catenin pathway in cervical cancer.

Hypoxia-activated DLL4/NOTCH-EDN1 signaling maintains fibroblast activation and endothelial crosstalk in a human dermal fibroblast model of keloid-like remodeling.

The diagnostic value of miR-4281 for knee osteoarthritis and its mechanism of action on the extracellular matrix of chondrocytes and apoptosis.

Leveraging non-concurrent controls for time-to-event endpoints in platform trials for infectious diseases.

C5aR1 and C5aR2 deficiency confer different degrees of protection against imiquimod-induced psoriasiform dermatitis.

Association of VISTA and BTLA polymorphisms with the risk of non-HBV and non-HCV related hepatocellular carcinoma in Western Guangxi, China: a pilot case-control study.

An Observational Study of Programmed Cell Death In Hypertrophic Scars and Keloids Based on Bibliometric Analysis.

Chronic Myeloid Leukemia Progressing to Early T-Cell Precursor Lymphoblastic Blast Phase Following Treatment Default: An Integrated Morphologic, Immunophenotypic, Cytogenetic, and Molecular Case Report.

Refining risk in historically high-risk pediatric B-cell acute lymphoblastic leukemia: response kinetics and outcomes.

Constitutional chromosomal aberration, t(4;12) (q23;p11), in a patient with Ph1 positive chronic myelocytic leukemia

Related Experiment Videos

Related Concept Videos

Related Articles